Dr. Frank Mathias in an interview with the German edition "Biotechnology 2022" of GoingPublic

Dr. Frank Mathias in an interview with the German edition "Biotechnology 2022" of GoingPublic

In an interview with Going Public, our CEO, Dr. Frank Mathias, shares his thoughts on what makes Germany stand out as a manufacturing hub compared to other nations, where opportunities and potential for improvements lie, where politics could have an essential influence on the future development of the industry, and where and how the industry itself can prove its resilience.

Click here for the complete interview (in German): https://www.goingpublic.de/wp-content/uploads/epaper/epaper-Life-Sciences-3-2022/#12 

 

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com